FDA
-
-
-
-
-
-
-
Assembly Biosciences Provides Update on the Ongoing Phase 2 Extension Study of Vebicorvir in Patients with Chronic Hepatitis B Virus Infection
-
-
-
-
-
-
-
Assembly Biosciences Reports Updates on Corporate Progress and First Quarter 2020 Financial Results
-
-
-
-
-
-
-
Assembly Biosciences Reports Third Quarter 2019 Financial Results and Recent Highlights
-
-
-
-
-
-
-
Assembly Biosciences Announces Changes to Senior Leadership Team
-
-
-
-
-
-
-
Assembly Biosciences Announces Second Quarter 2018 Financial Results
-
-
-
-
-
-
-
Allergan Enters Into Licensing Agreement with Assembly Biosciences to Obtain Worldwide Rights to Microbiome Gastrointestinal Development Programs
251,740 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All